Recorded webinars

Heavy menstrual bleeding (HMB) - when to investigate, treat or refer

Heavy menstrual bleeding (HMB) - when to investigate, treat or refer

Watch now

Recorded November 13 2019 | 7.30pm - 8.30pm

Description

This recording discusses treatment options for HMB including Qlaira (Estradiol valerate/dienogest). We note that Qlaira is currently not being promoted due to out of stock status.

 

Welcome & Introduction

 

Learning Objectives:

  • Identifying HMB, key questions to ask your patients
  • When do you need to examine?
  • What investigations are required?
  • What treatment options are available?
  • What are the ’red flags’ and who do you need to refer?

 

Question and Answer session with Dr Diana Mansour

 

Summary & close

 

This promotional meeting is part of the Women’s Health Matters Educational Programme that is organised and fully funded by Bayer.

Speakers

Dr Diana Mansour

 

Consultant in Community Gynaecology and Reproductive Health Care, FSRH Senior Vice President. Newcastle Hospitals, United Kingdom.

Dr Diana Mansour

Dr Diana Mansour is a Consultant in Community Gynaecology and Reproductive Health Care and has been an Associate Clinical Lecturer at the University of Newcastle since 1997. In addition Dr Mansour is the Senior Vice President for the Faculty of Sexual and Reproductive Healthcare.

 

Dr Mansour was the first accredited subspecialty trainee in Community Gynaecology and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists. Dr Mansour is first author to over 90 peer-reviewed publications and has most recently published in Contraception and the BMJ SRH.

 

Dr Mansour’s areas of expertise include acceptability of contraceptive methods, non-contraceptive benefits of contraception, development of long-term methods of contraception, changes in health service provision, medical management of menstrual disorders and management of the menopause.

 

Watch now

Recorded November 13 2019 | 7.30pm - 8.30pm

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: pvuk@bayer.com

 

Further information is available on the “contact” tab at www.bayer.co.uk.